3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Prostatic Neoplasms
17
Neoplasms
13
Breast Neoplasms
12
Neuroendocrine Tumors
8
Carcinoma, Non-Small-Cell Lung
8
Lung Neoplasms
7
Neoplasm Metastasis
6
Esophageal Neoplasms
5
Uterine Cervical Neoplasms
4
Stomach Neoplasms
4
Multiple Myeloma
4
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Mouth Neoplasms
3
Lymphoma, Non-Hodgkin
3
Glioma
3
Esophageal Squamous Cell Carcinoma
3
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplastic Cells, Circulating
2
Nasopharyngeal Carcinoma
2
Multiple Pulmonary Nodules
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Liver Neoplasms
2
Leukemia
2
Hypoxia
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Interventions
Echocardiography
14
Doxorubicin
10
Exercise
8
Electrocardiography
7
Trastuzumab
6
Cyclophosphamide
5
Carvedilol
5
Docetaxel
3
Atorvastatin
3
salicylhydroxamic acid
2
sacubitril and valsartan sodium hydrate drug combination
2
empagliflozin
2
dapagliflozin
2
Tablets
2
Social Determinants of Health
2
Silymarin
2
Magnetic Resonance Spectroscopy
2
Ivabradine
2
High-Intensity Interval Training
2
Exercise Test
2
Chemoradiotherapy
2
Blood Specimen Collection
2
Bisoprolol
2
Antineoplastic Agents
2
Anthracyclines
2
sulforaphane
1
schizandrin
1
pegfilgrastim
1
nicotinamide-beta-riboside
1
mitoquinone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Cardiotoxicity
×
Positron Emission Tomography Computed Tomography
×
Clear all
NCT06597045
2024-09-19
BIOCAPRI
NHS Greater Glasgow and Clyde
Active not recruiting
60 enrolled